SCHEMBL1282307

SCHEMBL1282307

CC(C)(C)C(O)(CCCCCOc1ccc(Cl)cc1F)Cn1ncnc1S

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 1/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 1/20 0.35
HTR1A P08908 1/20 0.33
HTR7 P34969 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.33
AR P10275 1/20 0.32
LTB4R Q15722 3/20 0.31
LTB4R2 Q9NPC1 2/20 0.31
SMN1; SMN2 Q16637 4/20 0.31
LMNA P02545 2/20 0.30
KDM4E B2RXH2 1/20 0.30
DRD2 P14416 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30
NPC1 O15118 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1281725 0.99 S1PR4 (0.36) S1PR4ALDH1A1CYP3A4HTR1AHTR7
SCHEMBL1282264 0.96 S1PR4 (0.36) S1PR4ALDH1A1CYP3A4HTR1AHTR7
SCHEMBL2122104 0.93 DRD2 (0.33) S1PR4ALDH1A1CYP3A4HTR1AHTR7
SCHEMBL1281978 0.90 HSP90AB1 (0.32) S1PR4ALDH1A1CYP3A4LTB4RLTB4R2
SCHEMBL1282510 0.90 HPGD (0.39) S1PR4ALDH1A1CYP3A4SMN1; SMN2MEN1
SCHEMBL1282429 0.89 HPGD (0.40) S1PR4ALDH1A1CYP3A4SMN1; SMN2MEN1
SCHEMBL1281730 0.89 HSP90AB1 (0.32) ALDH1A1CYP3A4LMNAMEN1KMT2A
SCHEMBL1282368 0.86 PPARA (0.37) S1PR4ALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL1282197 0.86 HPGD (0.41) S1PR4ALDH1A1CYP3A4SMN1; SMN2MEN1
SCHEMBL1282161 0.86 HSP90AB1 (0.33) ALDH1A1CYP3A4LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives BASF SE (DE) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives ERG28, CYP51A1, DPM1 S1PR4 2670/4885ALDH1A1 1943/4885CYP3A4 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.